Order Article Reprints

Dreymann N, Wuensche J, Sabrowski W, Moeller A, Czepluch D, Vu Van D, Fuessel S, Menger MM. Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA. International Journal of Molecular Sciences. 2022; 23(9):4890. https://doi.org/10.3390/ijms23094890

Dreymann, Nico, Julia Wuensche, Wiebke Sabrowski, Anja Moeller, Denise Czepluch, Dana Vu Van, Susanne Fuessel, and Marcus M. Menger. 2022. "Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA" International Journal of Molecular Sciences 23, no. 9: 4890. https://doi.org/10.3390/ijms23094890

Dreymann, N., Wuensche, J., Sabrowski, W., Moeller, A., Czepluch, D., Vu Van, D., Fuessel, S., & Menger, M. M. (2022). Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA. International Journal of Molecular Sciences, 23(9), 4890. https://doi.org/10.3390/ijms23094890